Jaihwan Kim

Associate Professor

Seoul National University Hospital

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jaihwan Kim is an Associate Professor at Seoul National University Bundang Hospital in South Korea. His research focuses on pancreatic cancer, particularly regarding diagnostic performance and prognostic factors. Recent articles highlight his work on the clinical implications of procalcitonin levels, the metabolic response in PET/CT scans, and treatment outcomes for pancreatic and biliary tract cancers.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Jun Suh Lee

Seoul National University Hospital

SOUTH KOREA

View details

Jin-Hyeok Hwang

Seoul National University Hospital

SOUTH KOREA

View details

Dong Woo Shin

Seoul National University Hospital

SOUTH KOREA

View details

Seung Hyun Won

Research Associate Professor

Seoul National University Hospital

SOUTH KOREA

View details

Jin Won Kim

Professor

Seoul National University Hospital

SOUTH KOREA

View details

Seungmin Bang

Yonsei University College of Medicine

SOUTH KOREA

View details

Huapyong Kang

Assistant Professor

Gachon University Gil Medical Center

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jaihwan Kim

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Clinical Implications of Elevated Initial Procalcitonin Levels in Febrile Patients with Pancreatic Cancer

Prognostic Value of the Metabolic Response on Serial 18F-FDG PET/CT in Pancreatic Cancer

Small Cell Transformation in Pancreatic Metastasis from EGFR-Mutated Lung Adenocarcinoma Following TKI

Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery

Prognostic value of the TP53 mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX

Factors Influencing the Diagnostic Performance of Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy after the First Inconclusive Diagnosis of Pancreatic Solid Lesions

Current Trends and Practice Patterns for Difficult Bile Ducts Stones in Korea

Continued adjuvant FOLFIRINOX for BRPC or LAPC after neoadjuvant FOLFIRINOX

Impact of histopathological type on the prognosis of ampullary carcinoma: A systematic review and meta-analysis

Real-World Outcomes of Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy Regimen for Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis

Prediction model using clinical factors for radiation exposure during endoscopic retrograde cholangiopancreatography

Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma

Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Resection for Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy

The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer

Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resected pancreatic ductal adenocarcinoma: A biomarker stratified prospective trial

Collaborators (7)

Jun Suh Lee

Jin-Hyeok Hwang

Dong Woo Shin

Seung Hyun Won

Jin Won Kim

Seungmin Bang

Huapyong Kang

Make your next move.